Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's disease treatment
- PMID: 18596151
- PMCID: PMC6670979
- DOI: 10.1523/JNEUROSCI.1870-08.2008
Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's disease treatment
Figures
Comment on
-
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.J Neurosci. 2008 Mar 26;28(13):3384-91. doi: 10.1523/JNEUROSCI.0185-08.2008. J Neurosci. 2008. PMID: 18367605 Free PMC article.
Similar articles
-
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.J Neurosci. 2008 Mar 26;28(13):3384-91. doi: 10.1523/JNEUROSCI.0185-08.2008. J Neurosci. 2008. PMID: 18367605 Free PMC article.
-
Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP.PLoS One. 2009 Jun 17;4(6):e5949. doi: 10.1371/journal.pone.0005949. PLoS One. 2009. PMID: 19536328 Free PMC article.
-
alpha-synuclein and LRRK2: partners in crime.Neuron. 2009 Dec 24;64(6):771-3. doi: 10.1016/j.neuron.2009.12.017. Neuron. 2009. PMID: 20064381 Free PMC article.
-
LRRK2 and neurodegeneration.Acta Neuropathol. 2009 Mar;117(3):227-46. doi: 10.1007/s00401-008-0478-8. Epub 2009 Jan 14. Acta Neuropathol. 2009. PMID: 19142648 Review.
-
A trojan horse for Parkinson's disease.Sci Signal. 2010 Apr 6;3(116):pe13. doi: 10.1126/scisignal.3116pe13. Sci Signal. 2010. PMID: 20371768 Review.
Cited by
-
Quinones as Neuroprotective Agents.Antioxidants (Basel). 2023 Jul 20;12(7):1464. doi: 10.3390/antiox12071464. Antioxidants (Basel). 2023. PMID: 37508002 Free PMC article. Review.
-
Choice of biological source material supersedes oxidative stress in its influence on DJ-1 in vivo interactions with Hsp90.J Proteome Res. 2011 Oct 7;10(10):4388-404. doi: 10.1021/pr200225c. Epub 2011 Aug 26. J Proteome Res. 2011. PMID: 21819105 Free PMC article.
-
Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?Mol Cell Biochem. 2014 Jan;386(1-2):45-61. doi: 10.1007/s11010-013-1844-y. Epub 2013 Oct 5. Mol Cell Biochem. 2014. PMID: 24096700 Review.
-
The role of Aha1 in cancer and neurodegeneration.Front Mol Neurosci. 2024 Dec 24;17:1509280. doi: 10.3389/fnmol.2024.1509280. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39776493 Free PMC article. Review.
-
Heat shock protein 90 is a potential therapeutic target for ameliorating skeletal muscle abnormalities in Parkinson's disease.Neural Regen Res. 2014 Mar 15;9(6):616-21. doi: 10.4103/1673-5374.130105. Neural Regen Res. 2014. PMID: 25206864 Free PMC article.
References
-
- Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, Ash P, Shoraka S, Zlatkovic J, Eckman CB, Patterson C, Dickson DW, Nahman NS, Jr, Hutton M, Burrows F, Petrucelli L. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest. 2007;117:648–658. - PMC - PubMed
-
- Klein C, Schlossmacher MG. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology. 2007;69:2093–2104. - PubMed
-
- Schapira AH, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Le Novère N, Obeso JA, Schwarzschild MA, Spampinato U, Davidai G. Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov. 2006;5:845–854. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical